We are a pharmaceutical research and development company that is focused on developing our product, Oxygent™, (perfluorochemical (“PFC”) emulsion) an intravascular oxygen carrier designed to augment oxygen delivery in surgical patients.
Company profile
Ticker
ALLP
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Alliance Pharmaceutical Corp
SEC CIK
Corporate docs
IRS number
141644018
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
18 Oct 13
10-Q
2010 Q1
Quarterly report
4 Jun 10
10-Q
2010 Q3
Quarterly report
4 Jun 10
10-Q
2010 Q2
Quarterly report
4 Jun 10
10-K
2009 FY
Annual report
21 May 10
8-K
Results of Operations and Financial Condition
20 Oct 09
8-K
Departure of Directors or Certain Officers
14 Sep 09
10-Q
2009 Q3
Quarterly report
15 May 09
10-Q
2009 Q2
Quarterly report
17 Feb 09
10-Q
2009 Q1
Quarterly report
14 Nov 08
Latest ownership filings
No filings